本页面由Tiger Trade Technology Pte. Ltd.提供服务

Revolution Medicines, Inc.

188.07
-5.8800-3.03%
成交量:187.70万
成交额:3.58亿
市值:403.10亿
市盈率:-21.08
高:193.61
开:191.57
低:187.14
收:193.95
52周最高:224.31
52周最低:47.45
股本:2.14亿
流通股本:1.85亿
量比:0.89
换手率:1.01%
股息:- -
股息率:- -
每股收益(TTM):-8.9212
每股收益(LYR):-5.9502
净资产收益率:-79.09%
总资产收益率:-30.12%
市净率:15.47
市盈率(LYR):-31.61

数据加载中...

2024/07/15

重要事件披露

Form 8-K - Current report
2024/07/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/24

重要事件披露

Form 8-K - Current report
2024/06/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/05/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities